Join the Amaryl group to help and get support from people like you.
Amaryl News
Long-Term Sulfonylurea Use Tied to Impaired Awareness of Hypoglycemia
TUESDAY, July 23, 2024 – The prevalence of impaired awareness of hypoglycemia (IAH) is high among patients using sulfonylureas long term, according to a study published in the July/August issue of...
FDA Medwatch Alert: Amaryl (glimepiride)
[October 26, 2004] FDA, Janssen Pharmaceutica Products, and Johnson & Johnson Pharmaceutical Research & Development notified healthcare professionals of reports of medication errors involving...